BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26657735)

  • 1. The spectrum of nasal involvement in systemic lupus erythematosus and its association with the disease activity.
    Kusyairi KA; Gendeh BS; Sakthiswary R; Shaharir SS; Haizlene AH; Yusof KH
    Lupus; 2016 Apr; 25(5):520-4. PubMed ID: 26657735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal mucosal involvement in lupus erythematosus.
    Robson AK; Burge SM; Millard PR
    Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):341-3. PubMed ID: 1526055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulceration and perforation of the nasal septum in systemic lupus erythematosus.
    Alcalá H; Alarcón-Segovia D
    N Engl J Med; 1969 Sep; 281(13):722-3. PubMed ID: 5821165
    [No Abstract]   [Full Text] [Related]  

  • 4. Asymptomatic nasal septal perforations in systemic lupus erythematosus.
    Reiter D; Myers AR
    Ann Otol Rhinol Laryngol; 1980; 89(1 Pt 1):78-80. PubMed ID: 7356271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for colonoscopy in patients with systemic lupus erythematosus.
    Iwamuro M; Okada H; Kato J; Tanaka T; Sada KE; Makino H; Yamamoto K
    Hepatogastroenterology; 2013; 60(128):1940-4. PubMed ID: 24719931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
    Choe JY; Park SH; Kim SK
    Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of nasal disease in an asthma clinic: when is an ENT opinion indicated?
    Stanton AE; McGarry GW; Carter R; Bucknall CE
    J Laryngol Otol; 2009 Jun; 123(6):613-8. PubMed ID: 18761762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD; Castrejón I; Pincus T
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
    Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
    Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of retrospective disease activity assessment in systemic lupus erythematosus.
    Arce-Salinas A; Cardiel MH; Guzmán J; Alcocer-Varela J
    J Rheumatol; 1996 May; 23(5):846-9. PubMed ID: 8724296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000.
    Yee CS; Isenberg DA; Prabu A; Sokoll K; Teh LS; Rahman A; Bruce IN; Griffiths B; Akil M; McHugh N; D'Cruz D; Khamashta MA; Maddison P; Zoma A; Gordon C
    Ann Rheum Dis; 2008 Jun; 67(6):873-6. PubMed ID: 17519277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
    Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
    Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
    Ribi C; Trendelenburg M; Gayet-Ageron A; Cohen C; Dayer E; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Lindner G; Koenig K; Otto P; Spertini F; Stoll T; Von Kempis J; Chizzolini C;
    Swiss Med Wkly; 2014; 144():w13990. PubMed ID: 25115978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive dysfunction in systemic lupus erythematosus in relation to disease activity and damage].
    Dorman G; Micelli M; Cosentino V; Ottone L; Nuñez MR; Mangone C; Rey RC; Kerzberg E; Genovese O
    Medicina (B Aires); 2017; 77(4):257-260. PubMed ID: 28825566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonography and detection of subclinical joints and tendons involvements in Systemic Lupus erythematosus (SLE) patients: A cross-sectional multicenter study.
    Salliot C; Denis A; Dernis E; Andre V; Perdriger A; Albert JD; Mammou Mraghni S; Griffoul-Espitalier I; Hamidou M; Le Goff B; Joulin SJ; Marhadour T; Richez C; Poursac N; Lazaro E; Rist S; Corondan A; Quinten C; Martaillé V; Valéry A; Ducourau E
    Joint Bone Spine; 2018 Dec; 85(6):741-745. PubMed ID: 29454670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nasal septum perforation in disseminated lupus erythematosus, case report and literature review].
    Bach GL
    Z Rheumatol; 1980; 39(1-2):22-7. PubMed ID: 7424195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus.
    Martin-Rodriguez S; Reverter JC; Tàssies D; Espinosa G; Heras M; Pino M; Escolar G; Diaz-Ricart M
    Lupus; 2015 Oct; 24(11):1143-9. PubMed ID: 25824235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.